Home » BD Claims Influenza Detection Test Meets FDA's New Performance Requirements
BD Claims Influenza Detection Test Meets FDA's New Performance Requirements
New Jersey–based BD (Becton, Dickinson and Company) says its BD Veritor system flu A+B, a digital immunoassay for the rapid detection of influenza, meets the new FDA performance requirements introduced when the agency reclassified rapid flu tests from Class I to Class II.
The shift from Class I to Class II devices was prompted by the failure of some point-of-care flu tests during the 2009 pandemic. — Cynthia Jessup
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May